Coloplast A/S provided earnings guidance for Fiscal year 2023-2024. For the year company expects, organic revenue growth of around 8% and an EBIT margin of 27%-28%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
840.8 DKK | +1.35% | +1.94% | +8.91% |
06/06 | Transcript : Coloplast A/S - Analyst/Investor Day | |
15/05 | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.91% | 27.39B | |
-41.00% | 2.63B | |
+26.30% | 2.48B | |
-23.19% | 2.31B | |
+5.99% | 2.21B | |
-14.16% | 1.81B | |
+33.51% | 1.34B | |
+25.56% | 1.32B | |
+1.18% | 1.25B | |
+32.62% | 1.04B |
- Stock Market
- Equities
- COLO B Stock
- News Coloplast A/S
- Coloplast A/S Provides Earnings Guidance for Fiscal Year 2023-2024